Gamida Cell Ltd., a leading cellular and immune therapeutics company, and Be The Match BioTherapies®, a subsidiary of the National Marrow Donor Program®/Be The Match® offering integrated platforms and ....
The first subject has been transplanted in an investigator-initiated study of Cordin for patients with severe aplastic anemia (AA) or hypoplastic myelodysplastic syndrome (MDS) who have no available matched donor. CordIn is produced by Gamida Cell.